Transposable Elements and Genome Deregulation in Ageing
Key Takeaways
- Transposable elements are abundant DNA sequences whose expression and movement are normally constrained by chromatin and other cellular defences. [1]
- Ageing and cellular senescence are often associated with weaker control of some transposable-element families, but the pattern varies by element, tissue, and experimental system. [1] [2]
- Deregulated elements may disturb cells through new insertions, altered transcription, DNA damage, or innate immune sensing of element-derived nucleic acids. [1] [5]
- Animal and cell studies support causal effects in specific models, while evidence that transposable elements are a general driver of normal human ageing remains incomplete. [7] [8] [9]
Transposable elements are repeated DNA sequences with the evolutionary capacity to change genomic location. Retrotransposons copy through an RNA intermediate, whereas DNA transposons use other mechanisms; in humans, most copies are old and unable to move, but a small subset of LINE-1 elements remains potentially active. Their biological significance in ageing therefore depends not simply on how much of the genome they occupy, but on whether particular copies are transcribed, translated, reverse-transcribed, or inserted into new sites. [1]
Who This Is Useful For
This page is for readers examining how epigenetic change, genomic instability, cellular senescence, and chronic inflammation can intersect during ageing. It also provides a framework for interpreting claims that age-associated transposable-element RNA necessarily proves active genomic movement.
How Cells Keep Transposable Elements Under Control
Cells suppress transposable elements at several stages. DNA methylation and repressive histone marks can package element-rich regions into less accessible chromatin, while sequence-specific repressors and small-RNA pathways can reduce transcription or destroy element-derived RNA. In mammalian cells, SIRT6 also helps repress LINE-1 by modifying the co-repressor KAP1 and supporting its association with heterochromatin protein HP1. [1] [3]
These systems overlap with broader genome-maintenance processes. That overlap is important: a change in a chromatin regulator may alter transposable elements, ordinary genes, DNA repair, and nuclear organization at the same time. An association between weakened silencing and ageing therefore does not by itself show that transposable elements are the initiating cause. [1] [7]
What Deregulation Means
“Activation” can refer to several distinct observations. Researchers may detect more RNA mapping to a transposable-element family, expression of an element-encoded protein, reverse-transcribed DNA in the cytoplasm, or a new insertion in genomic DNA. These are related steps, but one does not guarantee the next. Increased RNA is therefore evidence of altered transcriptional control, not automatically proof of mobilization. [1] [9]
Routes from Deregulation to Cellular Dysfunction
| Route | Mechanism | Strength of Evidence |
|---|---|---|
| Insertion and DNA damage | A competent element can generate a new genomic copy, potentially disrupting DNA or changing local regulation | Observed in several experimental systems, but not required for every harmful effect of element expression [2] [8] |
| Transcriptional disturbance | Element sequences can supply promoters or regulatory signals, while readthrough transcription and intron retention can increase element-mapping RNA | Supported by transcriptomic analyses; the direction of causality can be difficult to resolve [9] |
| Innate immune activation | LINE-1-derived cytoplasmic DNA can be sensed as misplaced nucleic acid and stimulate type I interferon signalling | Mechanistically supported in senescent cells and SIRT6-deficient or aged mouse models [5] [6] |
| Loss of chromatin control | Element expression can mark a wider failure of heterochromatin maintenance and genome regulation | Commonly associated with ageing, although it may be both a consequence and a contributor [1] [7] |
Evidence from Ageing Cells and Animals
In aged mouse liver and skeletal muscle, one study reported increased expression of several repetitive element families and higher genomic copy numbers for LINE-1 and MusD at advanced ages, consistent with mobilization in those tissues. Human fibroblasts undergoing replicative senescence also showed element-associated chromatin changes and increased repetitive-element activity. These observations established that age-related deregulation can extend beyond germ cells and cultured transformed cells. [2]
Drosophila experiments provide evidence that the relationship can affect organismal phenotypes. Age-related activation of several elements has been observed in the fly brain alongside neuronal decline. In separate experiments, age-associated element expression and transposition were reduced by manipulations that strengthened heterochromatin or RNA interference, and some of those manipulations extended lifespan. However, the altered regulators also control processes other than transposable elements, limiting how specifically the lifespan effects can be attributed. [4] [7]
More targeted fly experiments found that reducing expression of either of two retrotransposons extended lifespan even though single-nucleus genome sequencing did not detect a general age-related increase in new insertions. This result separates element expression from insertion and suggests that RNA or downstream regulatory effects can matter without widespread new genomic integration. [8]
LINE-1, Senescence, and Inflammatory Signalling
LINE-1 provides a mechanistic bridge between genome deregulation and inflammation. In cultured senescent human cells, LINE-1 transcription and cytoplasmic complementary DNA increased during late senescence. Genetic suppression of LINE-1 or inhibition of reverse transcription reduced the type I interferon response, supporting a pathway in which cytoplasmic LINE-1 DNA activates the cGAS–STING nucleic-acid sensing system. [5]
A related study found elevated LINE-1 transcription, cytoplasmic DNA, and interferon signalling in aged wild-type mice and in short-lived SIRT6-deficient mice. Suppressing LINE-1 reduced inflammatory and DNA damage markers in cells, while reverse-transcriptase inhibition improved outcomes in the SIRT6-deficient model. Because SIRT6 deficiency produces an unusually severe phenotype, these results demonstrate a causal pathway in that model rather than proving that the pathway has the same weight in normal human ageing. [6]
Evidence in Humans
Human evidence is strongest for association. Analyses of dermal fibroblast datasets found that many repetitive-element transcripts rose with donor age and could contribute to age prediction. Blood analyses have been less uniform: a large multi-omics study found little relationship with chronological age but associations between most retrotransposon classes and gene-expression signatures of biological ageing. Together, these findings argue against treating one tissue or one element family as a universal measure of ageing. [10] [11]
Measurement and Interpretation Limits
Repetitive sequences are difficult to assign to individual genomic copies using short sequencing reads. In addition, many transposable elements lie inside introns or near genes. Reanalysis of human and mouse datasets showed that age-related increases in reads assigned to transposable elements often tracked with intron retention and transcription beyond normal gene boundaries. Some apparent element expression may therefore reflect wider transcriptional dysregulation rather than autonomous activation of an element's own promoter. [9]
Stronger inference comes from combining RNA measurements with element-encoded protein, cytoplasmic DNA, insertion mapping, chromatin state, and perturbation experiments. Even then, results are specific to the elements, cell types, and models studied; “transposable elements” are not one uniform pathway. [1] [8] [9]
Evidence Quality and Open Questions
Confidence is high that some transposable-element families lose repression in particular ageing and senescence models. Confidence is also substantial that LINE-1-derived nucleic acids can activate innate immune signalling under defined experimental conditions. The evidence is less settled on how often new somatic insertions accumulate during normal ageing, how much they contribute to functional decline, and whether the same mechanisms dominate across human tissues. [1] [5] [8]
A central unresolved question is directionality. Age-related chromatin change and transcriptional errors can expose transposable elements, while element-derived RNA, DNA, and proteins can in turn add stress to genome regulation and immune signalling. Current evidence therefore supports a potential feedback loop more strongly than a single-cause model of ageing. [1] [9]
What This Does Not Mean
- Detecting transposable-element RNA does not by itself demonstrate a new genomic insertion. [9]
- Most human transposable-element copies are not capable of autonomous movement. [1]
- Age-related deregulation is not uniform across every element family, cell type, tissue, or species. [1] [11]
- Results from senescent cells, flies, or genetically altered mice do not establish the magnitude of an effect in normal human ageing. [6] [8]
Summary
Transposable-element deregulation links several recognised features of ageing biology: changing chromatin, imperfect transcriptional control, genomic instability, cellular senescence, and sterile inflammation. The clearest mechanistic evidence concerns specific elements in defined cell and animal models, particularly LINE-1-driven innate immune signalling. Human studies support age-related changes in repetitive-element regulation but remain heterogeneous, and transcript abundance alone cannot distinguish autonomous activation from broader transcriptional failure. Transposable elements are therefore best understood as possible participants in reciprocal genome deregulation, not as a proven single cause of ageing. [1] [5] [9]
References
- Gorbunova, V. et al. "The role of retrotransposable elements in ageing and age-associated diseases." Nature (2021). https://www.nature.com/articles/s41586-021-03542-y
- De Cecco, M. et al. "Transposable elements become active and mobile in the genomes of aging mammalian somatic tissues." Aging (2013). https://pmc.ncbi.nlm.nih.gov/articles/PMC3883704/
- Van Meter, M. et al. "SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age." Nature Communications (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC4185372/
- Li, W. et al. "Activation of transposable elements during aging and neuronal decline in Drosophila." Nature Neuroscience (2013). https://pmc.ncbi.nlm.nih.gov/articles/PMC3821974/
- De Cecco, M. et al. "LINE-1 derepression in senescent cells triggers interferon and inflammaging." Nature (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6519963/
- Simon, M. et al. "LINE1 derepression in aged wild-type and SIRT6-deficient mice drives inflammation." Cell Metabolism (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6449196/
- Wood, J. G. et al. "Chromatin-modifying genetic interventions suppress age-associated transposable element activation and extend life span in Drosophila." Proceedings of the National Academy of Sciences (2016). https://pmc.ncbi.nlm.nih.gov/articles/PMC5056045/
- Schneider, B. K. et al. "Expression of retrotransposons contributes to aging in Drosophila." Genetics (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC10213499/
- Pabis, K. et al. "A concerted increase in readthrough and intron retention drives transposon expression during aging and senescence." eLife (2024). https://pmc.ncbi.nlm.nih.gov/articles/PMC10990488/
- LaRocca, T. J. et al. "Repetitive elements as a transcriptomic marker of aging: Evidence in multiple datasets and models." Aging Cell (2020). https://pmc.ncbi.nlm.nih.gov/articles/PMC7412685/
- Tsai, Y.-T. et al. "Expression of most retrotransposons in human blood correlates with biological aging." eLife (2024). https://pmc.ncbi.nlm.nih.gov/articles/PMC11486490/
This content is provided for educational purposes only and does not constitute medical advice.